Publications - Han W . Tun, M.D.

Back to Research Profile

1. Shanafelt TD, Bowen DA, Venkat C, Slager SL, Zent CS, Kay NE, Reinalda M, Tun H, Sloan JA, Call TG. The physician-patient relationship and quality of life: lessons from chronic lymphocytic leukemia. Leuk Res 2009 Feb; 33(2):263-70. Epub 2008 Jul 25.
   View PubMed
2. Zubair AC, Grant R, Wu W, Tun H, Rivera C, Moreno-Aspitia A, Joyce M, Roy V, Colon-Otero G, Solberg LA. Platelet count is a sensitive predictor of autologous peripheral blood progenitor cell collection yield in previously treated plasma cell disease patients. Transfusion 2008 Jun; 48(6):1106-14. Epub 2008 Feb 25.
   View PubMed
3. Zubair AC, Grant R, Wu W, Tun H, Rivera C, Moreno-Aspitia A, Joyce M, Roy V, Colon-Otero G, Solberg LA. Platelet count is a sensitive predictor of autologous peripheral blood progenitor cell collection yield in previously treated plasma cell disease patients. Transfusion 2008 Jun; 48(6):1106-14 Epub 2008 Feb 25.
   View PubMed
4. Tun HW, Personett D, Baskerville KA, Menke DM, Jaeckle KA, Kreinest P, Edenfield B, Zubair AC, O'Neill BP, Lai WR, Park PJ, McKinney M. Pathway analysis of primary central nervous system lymphoma. Blood 2008 Mar 15; 111(6):3200-10. Epub 2008 Jan 09.
   View PubMed
5. Tun HW, Personett D, Baskerville KA, Menke DM, Jaeckle KA, Kreinest P, Edenfield B, Zubair AC, O'Neill BP, Lai WR, Park PJ, McKinney M. Pathway analysis of primary central nervous system lymphoma. Blood 2008 Mar 15; 111(6):3200-10. Epub 2008-01-09.
   View PubMed
6. Tun HW, Personett D, Baskerville KA, Menke DM, Kreinest P, Edenfield B, Jaeckle KA, O'Neill BP, Lai W, Park PJ, Mckinney M. Pathway Analysis of primary central nervous system lymphoma. Blood First Edition January 9, 2008.
   View PubMed
7. Zubair AC, Grant R, Wu W, Tun HW, Rivera C, Moreno-Aspitia A, Joyce M, Roy V, Colon-Otero G, Solberg LA. Platelet count is a sensitive predictor of autologous peripheral blood progenitor cell collection yield in previously treated plasma cell disease patients. Transfusion in press 2008.
   View PubMed
8. Zou YS, Fink SR, Stockero KJ, Paternoster SF, Smoley SA, Tun HW, Reeder CB, Tefferi A, Dewald GW. Efficacy of conventional cytogenetics and FISH for EGR1 to detect deletion 5q in hematological disorders and to assess response to treatment with Lenalidomide. Leukemia Research 2007 Sept; 31(9):1193-1197.
   View PubMed
9. Zou YS, Fink SR, Stockero KJ, Paternoster SF, Smoley SA, Tun HW, Reeder CB, Tefferi A, Dewald GW. Efficacy of conventional cytogenetics and FISH for EGR1 to detect deletion 5q in hematological disorders and to assess response to treatment with Lenalidomide. Leuk Res 2007 Sep; 31(9):1185-9. Epub 2006 Nov 27.
   View PubMed
10. Tun HW, Wallace KH, Grinton SF, Khoor A, Burger CD. Etanercept therapy for late-onset idiopathic pneumonia syndrome after nonmyeloablative allogeneic hematopoietic stem cell transplantation. Transplant Proc 2005 Dec; 37(10):4492-6.
    View PubMed
11. Tun HW, Krishna M, Menke DM. Hepatitis C-related posttransplant plasma cell proliferative disorder with hepatitis C virus in neoplastic cells: A new posttransplant disease entity? Transplant Proc 2004 Nov; 36(9):2692-6.
    View PubMed
12. Tun H, Marlow L, Pinnix I, Kinsey R, Sambamurti K. Lipid rafts play an important role in A beta biogenesis by regulating the beta-secretase pathway. J Mol Neurosci 2002 Aug-Oct; 19(1-2):31-5.
    View PubMed
13. Pinnix I, Musunuru U, Tun H, Sridharan A, Golde T, Eckman C, Ziani-Cherif C, Onstead L, Sambamurti K. A novel gamma -secretase assay based on detection of the putative C-terminal fragment-gamma of amyloid beta protein precursor. J Biol Chem 2001 Jan 5; 276(1):481-7.
    View PubMed